Codiak Biosciences Inc
NASDAQ:CDAK 3:59:52 PM EDT
Earnings Announcements
Codiak Biosciences Reports Second Quarter 2022 Financial Results And Operational Progress
Published: 08/04/2022 20:58 GMT
Codiak Biosciences Inc (CDAK) - Codiak Biosciences Reports Second Quarter 2022 Financial Results and Operational Progress.
Codiak Biosciences, Inc. - Q2 Total Revenues $13.1 Million, Compared to $0.9 Million.
Codiak Biosciences, Inc. - Q2 Total Revenues $13.1 Million, Compared to $0.9 Million.
Revenue is expected to be $0.59 Million
Adjusted EPS is expected to be -$0.77
Next Quarter Revenue Guidance is expected to be $0.59 Million
Next Quarter EPS Guidance is expected to be -$0.54
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.77
Next Quarter Revenue Guidance is expected to be $0.59 Million
Next Quarter EPS Guidance is expected to be -$0.54
More details on our Analysts Page.